Thermo Fisher Scientific | TMO - Operating Expenses


Thermo Fisher Scientific reported $9.81B in Operating Expenses for its fiscal quarter ending in June of 2026.





Operating Expenses Change Date
Abbott USD 10.46B 1.15B Jun/2026
Agilent USD 1.43B 2M Jun/2026
Becton, Dickinson and Co. USD 24.42B 283M Jun/2026
Bio Techne USD 235.92M 5.5M Mar/2026
Bio-Rad Laboratories USD 7.17B 322.6M Jun/2026
Boston Scientific USD 4.2B 49M Jun/2026
Bruker USD 768.9M 44.3M Jun/2026
Charles River Laboratories USD 2.84B 1.96B Jun/2026
Danaher USD 52.58B 368M Jun/2026
Dentsply International USD 1.35B 33M Jun/2026
Edwards Lifesciences USD 1.22B 87.6M Jun/2026
General Electric Aerospace USD 17.64B 417M Jun/2026
Henry Schein USD 3.26B 84M Jun/2026
Illumina USD 899M 47M Jun/2026
Intuitive Surgical USD 1.91B 3.6M Jun/2026
IQVIA Holdings USD 1.77B 4.45B Jun/2026
Laboratory Of America USD 3.27B 146.9M Jun/2026
Medtronic USD 7.92B 203M Jun/2026
Mettler Toledo International USD 739.77M 26.57M Jun/2026
Myriad Genetics USD 212.8M 16.2M Dec/2025
Olympus JPY 210.33B 58.09B Jun/2026
OraSure Technologies USD 40.35M 2.45M Dec/2025
Quest Diagnostics USD 2.58B 88M Jun/2026
Repligen USD 183M 8.72M Jun/2026
Revvity USD 603.55M 24.8M Jun/2026
Stryker USD 4.8B 118M Jun/2026
Thermo Fisher Scientific USD 9.81B 716M Jun/2026
Veracyte USD 126.36M 6.37M Jun/2026
Waters USD 527M 592M Jun/2026
Zimmer Biomet Holdings USD 1.83B 140.7M Jun/2026